Could the expectation that men need to be "manly" end up damaging their hearts? Researchers reveal a concerning trend among ...

Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

The main findings of the paper revealed that Black patients were underrepresented in clinical trials, particularly with ...

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive ...

People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than ...

In a pooled analysis of clinical trial data on diabetic patients at high cardiovascular risk or with chronic kidney disease, canagliflozin demonstrated consistent benefits across the spectrum of age ...

The lives of Americans could be dramatically improved, and in thousands of cases even saved, by increasing access to ...

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

Heartburn is a symptom, like acid reflux, of GERD. Not everyone with heartburn has GERD. Learn when heartburn is temporary or ...